Skip to main content

Antibiotics

Featured Article

News
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
From Veterans Health Today
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network
News
02/26/2021
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling...
02/26/2021
Pharmacy Learning Network
News
01/04/2021
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows...
01/04/2021
Pharmacy Learning Network
News
06/03/2020
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for...
06/03/2020
Pharmacy Learning Network
News
03/27/2020
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used...
03/27/2020
Pharmacy Learning Network
News
02/21/2020
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of...
02/21/2020
Pharmacy Learning Network
News
02/03/2020
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend...
02/03/2020
Pharmacy Learning Network

Newsfeed

News
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
News
10/22/2019
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial...
10/22/2019
Pharmacy Learning Network
News
05/01/2019
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings,...
05/01/2019
Pharmacy Learning Network
News
03/07/2019
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions...
03/07/2019
Pharmacy Learning Network
News
05/11/2018
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk...
05/11/2018
Pharmacy Learning Network
News
04/05/2018
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over...
04/05/2018
Pharmacy Learning Network
News
08/20/2026
Rebecca Amrick
Diovan (valsartan) tablets are under a voluntary Class II recall after failing to meet dissolution specifications.
Diovan (valsartan) tablets are under a voluntary Class II recall after failing to meet dissolution specifications.
Diovan (valsartan) tablets are...
08/20/2026
Pharmacy Learning Network
News
08/20/2026
Rebecca Amrick
A voluntary Class II recall has been issued for clindamycin palmitate hydrochloride oral solution due to the presence of foreign particles in the product.
A voluntary Class II recall has been issued for clindamycin palmitate hydrochloride oral solution due to the presence of foreign particles in the product.
A voluntary Class II recall has...
08/20/2026
Pharmacy Learning Network
News
08/20/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for Kian Pee Wan capsules due to the presence of undeclared drug ingredients (dexamethasone and cyproheptadine), affecting 71 bottles.
The US Food and Drug Administration (FDA) has issued a Class I recall for Kian Pee Wan capsules due to the presence of undeclared drug ingredients (dexamethasone and cyproheptadine), affecting 71 bottles.
The US Food and Drug...
08/20/2026
Pharmacy Learning Network
PharmLaw
08/19/2026
Hannah Musick
AstraZeneca has joined AbbVie and Novartis in challenging Illinois’ new 340B contract pharmacy law, adding to a growing national legal battle over state authority to regulate manufacturer distribution requirements and compliance data within...
AstraZeneca has joined AbbVie and Novartis in challenging Illinois’ new 340B contract pharmacy law, adding to a growing national legal battle over state authority to regulate manufacturer distribution requirements and compliance data within...
AstraZeneca has joined AbbVie...
08/19/2026
Pharmacy Learning Network
News
08/13/2026
Rebecca Amrick
Mirabegron extended-release tablets are under a voluntary Class II recall after an N-nitroso mirabegron impurity was found in the product, violating Current Good Manufacturing Practice specifications.
Mirabegron extended-release tablets are under a voluntary Class II recall after an N-nitroso mirabegron impurity was found in the product, violating Current Good Manufacturing Practice specifications.
Mirabegron extended-release...
08/13/2026
Pharmacy Learning Network
News
08/13/2026
Rebecca Amrick
A voluntary Class II recall has been issued for dicyclomine hydrochloride due to reports of empty capsules, affecting 6408 bottles.
A voluntary Class II recall has been issued for dicyclomine hydrochloride due to reports of empty capsules, affecting 6408 bottles.
A voluntary Class II recall has...
08/13/2026
Pharmacy Learning Network
News
08/13/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for cyclophosphamide injection due to the presence of steel particles, affecting 5541 vials.
The US Food and Drug Administration (FDA) has issued a Class I recall for cyclophosphamide injection due to the presence of steel particles, affecting 5541 vials.
The US Food and Drug...
08/13/2026
Pharmacy Learning Network
PharmLaw
08/12/2026
Hannah Musick
Eli Lilly has filed 6 lawsuits against companies allegedly selling unapproved versions of investigational obesity drug retatrutide, highlighting growing legal and regulatory scrutiny of unauthorized products entering the rapidly expanding...
Eli Lilly has filed 6 lawsuits against companies allegedly selling unapproved versions of investigational obesity drug retatrutide, highlighting growing legal and regulatory scrutiny of unauthorized products entering the rapidly expanding...
Eli Lilly has filed 6 lawsuits...
08/12/2026
Pharmacy Learning Network
News
08/06/2026
Rebecca Amrick
Dorzolamide and timolol maleate ophthalmic solution is subject to a voluntary Class II recall after the firm received complaints about defective containers.
Dorzolamide and timolol maleate ophthalmic solution is subject to a voluntary Class II recall after the firm received complaints about defective containers.
Dorzolamide and timolol maleate...
08/06/2026
Pharmacy Learning Network
News
08/06/2026
Rebecca Amrick
A voluntary Class II recall has been issued for azelaic acid gel due to Current Good Manufacturing Practice (CGMP) deviations, resulting from the product’s abnormal texture.
A voluntary Class II recall has been issued for azelaic acid gel due to Current Good Manufacturing Practice (CGMP) deviations, resulting from the product’s abnormal texture.
A voluntary Class II recall has...
08/06/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network

Interactive Features